These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
||||||||||
| (State or other jurisdiction of | (I.R.S. Employer | ||||||||||
| incorporation or organization) | Identification No.) | ||||||||||
|
|
|||||||||||
|
|
|
|
|||||||||
| (Address of principal executive offices) | (Zip Code) | ||||||||||
| Title of Each Class | Trading Symbols | Name of Each Exchange on Which Registered | ||||||
|
|
|
|
||||||
|
|
|
|
||||||
|
|
☒ | Accelerated filer | ☐ | ||||||||
| Non-accelerated filer | ☐ | Smaller reporting company |
|
||||||||
| Emerging growth company |
|
||||||||||
| TABLE OF CONTENTS | PAGE | ||||||||||
| Abbreviation/Term | Definition | ||||
| 2020 10-K | Annual Report on Form 10-K for the year ended December 31, 2020 | ||||
| 2020 Period | Nine months ended September 30, 2020 | ||||
| 2020 Quarter | Three months ended September 30, 2020 | ||||
| 2021 Period | Nine months ended September 30, 2021 | ||||
| 2021 Quarter | Three months ended September 30, 2021 | ||||
| 3ME | Three months ended | ||||
| 9ME | Nine months ended | ||||
| AOCI | Accumulated other comprehensive income (loss) | ||||
| ASC | Accounting Standards Codification | ||||
| ASU | Accounting Standards Update | ||||
| Cont Ops | Continuing operations | ||||
| CPS | Convertible preferred stock | ||||
| COVID | Coronavirus pandemic | ||||
| DB plan | Defined benefit pension plan | ||||
| Disc Ops | Discontinued operations | ||||
| DOE | U.S. Department of Energy | ||||
| EPC | Engineering, procurement and construction | ||||
| EPS | Earnings (loss) per share | ||||
| Exchange Act | Securities Exchange Act of 1934 | ||||
| Fluor | Fluor Corporation and subsidiaries | ||||
| G&A | General and administrative expense | ||||
| GAAP | Accounting principles generally accepted in the United States | ||||
| ICFR | Internal control over financial reporting | ||||
| LNG | Liquefied natural gas | ||||
| NCI | Noncontrolling interests | ||||
| NM | Not meaningful | ||||
| NuScale | NuScale Power, LLC | ||||
| OCI | Other comprehensive income (loss) | ||||
| PP&E | Property, plant and equipment | ||||
| Q3 2021 10-Q | Quarterly Report on Form 10-Q for the quarter ended September 30, 2021 | ||||
| RSU | Restricted stock unit | ||||
| RUPO | Remaining unsatisfied performance obligations | ||||
| SEC | Securities and Exchange Commission | ||||
| Stork | Stork Holding B.V. and subsidiaries | ||||
| SMR | Small modular reactor | ||||
| VIE | Variable interest entity | ||||
|
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||
| (in thousands, except per share amounts) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||
| Cost of revenue |
|
|
|
|
|||||||||||||||||||
| Gross profit |
|
|
|
|
|||||||||||||||||||
| G&A |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Impairment, restructuring and other exit costs |
|
|
(
|
(
|
|||||||||||||||||||
| Foreign currency gain (loss) |
|
(
|
(
|
|
|||||||||||||||||||
| Operating profit |
|
|
|
|
|||||||||||||||||||
| Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Interest income |
|
|
|
|
|||||||||||||||||||
| Earnings (loss) from Cont Ops before taxes |
|
|
|
|
|||||||||||||||||||
| Income tax expense (benefit) |
|
|
|
(
|
|||||||||||||||||||
| Net earnings (loss) from Cont Ops |
|
|
|
|
|||||||||||||||||||
|
Less: Net earnings (loss) from Cont Ops
attributable to NCI
|
(
|
|
|
|
|||||||||||||||||||
| Net earnings (loss) from Cont Ops attributable to Fluor |
|
|
(
|
|
|||||||||||||||||||
| Net earnings (loss) from Disc Ops attributable to Fluor |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Net earnings (loss) attributable to Fluor | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Less: Dividends on CPS |
|
|
|
|
|||||||||||||||||||
| Net earnings (loss) available to Fluor common stockholders | $ |
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||
| Basic EPS available to Fluor common stockholders | |||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
|||||||||||||||||||
| Diluted EPS available to Fluor common stockholders | |||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ |
|
$ |
|
$ |
(
|
$ |
|
|||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
|||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||
| (in thousands) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net earnings (loss) | $ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| OCI, net of tax: | ||||||||||||||||||||||||||
| Foreign currency translation adjustment |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Ownership share of equity method investees’ OCI |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| DB plan adjustments |
|
|
|
|
||||||||||||||||||||||
| Unrealized gain (loss) on hedges |
(
|
|
(
|
|
||||||||||||||||||||||
| Total OCI, net of tax |
(
|
|
(
|
(
|
||||||||||||||||||||||
| Comprehensive income (loss) |
|
|
(
|
(
|
||||||||||||||||||||||
| Less: Comprehensive income (loss) attributable to NCI |
(
|
|
|
|
||||||||||||||||||||||
| Comprehensive income (loss) attributable to Fluor | $ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| (in thousands, except share and per share amounts) |
September 30,
2021 |
December 31,
2020 |
||||||||||||
| ASSETS | ||||||||||||||
| Current assets | ||||||||||||||
|
Cash and cash equivalents ($
|
$ |
|
$ |
|
||||||||||
|
Marketable securities ($
|
|
|
||||||||||||
|
Accounts receivable, net ($
|
|
|
||||||||||||
|
Contract assets ($
|
|
|
||||||||||||
|
Other current assets ($
|
|
|
||||||||||||
| Current assets held for sale |
|
|
||||||||||||
| Total current assets |
|
|
||||||||||||
| Noncurrent assets | ||||||||||||||
|
PP&E, net ($
|
|
|
||||||||||||
| Investments |
|
|
||||||||||||
| Deferred taxes |
|
|
||||||||||||
| Deferred compensation trusts |
|
|
||||||||||||
| Goodwill |
|
|
||||||||||||
|
Other assets ($
|
|
|
||||||||||||
| Noncurrent assets held for sale |
|
|
||||||||||||
| Total noncurrent assets |
|
|
||||||||||||
| Total assets | $ |
|
$ |
|
||||||||||
| LIABILITIES AND EQUITY | ||||||||||||||
| Current liabilities | ||||||||||||||
|
Accounts payable ($
|
$ |
|
$ |
|
||||||||||
| Short-term borrowings |
|
|
||||||||||||
|
Contract liabilities ($
|
|
|
||||||||||||
|
Accrued salaries, wages and benefits ($
|
|
|
||||||||||||
|
Other accrued liabilities ($
|
|
|
||||||||||||
| Current liabilities related to assets held for sale |
|
|
||||||||||||
| Total current liabilities |
|
|
||||||||||||
| Long-term debt |
|
|
||||||||||||
| Deferred taxes |
|
|
||||||||||||
|
Other noncurrent liabilities ($
|
|
|
||||||||||||
| Noncurrent liabilities related to assets for sale |
|
|
||||||||||||
| Contingencies and commitments |
|
|
||||||||||||
| Equity | ||||||||||||||
| Shareholders’ equity | ||||||||||||||
|
Preferred stock — authorized
|
|
|
||||||||||||
|
Common stock — authorized
|
|
|
||||||||||||
| Additional paid-in capital |
|
|
||||||||||||
| AOCI |
(
|
(
|
||||||||||||
| Retained earnings |
|
|
||||||||||||
| Total shareholders’ equity |
|
|
||||||||||||
| NCI |
|
|
||||||||||||
| Total equity |
|
|
||||||||||||
| Total liabilities and equity | $ |
|
$ |
|
||||||||||
|
9ME
September 30, |
||||||||||||||
| (in thousands) | 2021 | 2020 | ||||||||||||
| OPERATING CASH FLOW | ||||||||||||||
| Net earnings (loss) | $ |
(
|
$ |
(
|
||||||||||
| Adjustments to reconcile net earnings (loss) to operating cash flow: | ||||||||||||||
| Impairment expense - Cont Ops |
|
|
||||||||||||
| Impairment expense - Disc Ops |
|
|
||||||||||||
| Depreciation |
|
|
||||||||||||
| Amortization of intangibles |
|
|
||||||||||||
| (Earnings) loss from equity method investments, net of distributions |
(
|
(
|
||||||||||||
| (Gain) loss on sales of assets incl. AMECO-North America |
|
|
||||||||||||
| Loss on debt repurchases |
|
|
||||||||||||
| Stock-based compensation |
|
|
||||||||||||
| Deferred taxes |
|
(
|
||||||||||||
| Net retirement plan accrual (contributions) |
(
|
(
|
||||||||||||
| Changes in assets and liabilities |
(
|
(
|
||||||||||||
| Other |
(
|
(
|
||||||||||||
| Operating cash flow |
(
|
|
||||||||||||
| INVESTING CASH FLOW | ||||||||||||||
| Purchases of marketable securities |
(
|
(
|
||||||||||||
| Proceeds from sales and maturities of marketable securities |
|
|
||||||||||||
| Capital expenditures |
(
|
(
|
||||||||||||
| Proceeds from sales of assets incl. AMECO-North America |
|
|
||||||||||||
| Investments in partnerships and joint ventures |
(
|
(
|
||||||||||||
| Other |
(
|
|
||||||||||||
| Investing cash flow |
(
|
(
|
||||||||||||
| FINANCING CASH FLOW | ||||||||||||||
| Proceeds from issuance of CPS |
|
|
||||||||||||
| Purchases and retirement of debt |
(
|
|
||||||||||||
| Debt extinguishment costs |
(
|
|
||||||||||||
| Dividends paid (on CPS in 2021 and common stock in 2020) |
(
|
(
|
||||||||||||
| Other borrowings (debt repayments) |
(
|
|
||||||||||||
| Distributions paid to NCI |
(
|
(
|
||||||||||||
| Capital contributions by NCI |
|
|
||||||||||||
| Taxes paid on vested restricted stock |
(
|
(
|
||||||||||||
| Other |
|
(
|
||||||||||||
| Financing cash flow |
|
|
||||||||||||
| Effect of exchange rate changes on cash |
(
|
(
|
||||||||||||
| Increase (decrease) in cash and cash equivalents |
(
|
|
||||||||||||
| Cash and cash equivalents at beginning of period |
|
|
||||||||||||
| Cash and cash equivalents at end of period | $ |
|
$ |
|
||||||||||
| (in thousands, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
| BALANCE AS OF JUNE 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Net earnings (loss) | — | — | — | — | — | — |
|
|
(
|
|
||||||||||||||||||||||
| OCI | — | — | — | — | — |
(
|
— |
(
|
|
(
|
||||||||||||||||||||||
| Issuance of CPS |
|
|
— | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
|
Dividends on CPS ($
|
— | — | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||
| Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
| Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
| Other NCI transactions | — | — | — | — |
|
— | — |
|
(
|
(
|
||||||||||||||||||||||
| Stock-based plan activity | — | — |
(
|
|
|
— |
|
|
— |
|
||||||||||||||||||||||
|
BALANCE AS OF
SEPTEMBER 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| (in thousands, except per share amounts) | Preferred Stock | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
||||||||||||||||||||||||
| Shares | Amount | Shares | Amount | |||||||||||||||||||||||||||||
|
BALANCE AS OF
DECEMBER 31, 2020 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| Net earnings (loss) | — | — | — | — | — | — |
(
|
(
|
|
(
|
||||||||||||||||||||||
| OCI | — | — | — | — | — |
(
|
— |
(
|
|
(
|
||||||||||||||||||||||
| Issuance of CPS |
|
|
— | — |
|
— | — |
|
— |
|
||||||||||||||||||||||
|
Dividends on CPS ($
|
— | — | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||||||
| Distributions to NCI | — | — | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||||||
| Capital contributions by NCI | — | — | — | — | — | — | — | — |
|
|
||||||||||||||||||||||
| Other NCI transactions | — | — | — | — |
|
— | — |
|
(
|
(
|
||||||||||||||||||||||
| Stock-based plan activity | — | — |
|
|
|
— |
|
|
— |
|
||||||||||||||||||||||
|
BALANCE AS OF
SEPTEMBER 30, 2021 |
|
$ |
|
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||
| (in thousands, except per share amounts) | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
|||||||||||||||||||
| Shares | Amount | |||||||||||||||||||||||||
| BALANCE AS OF JUNE 30, 2020 |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| Net earnings (loss) | — | — | — | — |
|
|
|
|
||||||||||||||||||
| OCI | — | — | — |
|
— |
|
(
|
|
||||||||||||||||||
| Distributions to NCI | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||
| Capital contributions by NCI | — | — | — | — | — | — |
|
|
||||||||||||||||||
| Other NCI transactions | — | — |
|
— | — |
|
|
|
||||||||||||||||||
| Stock-based plan activity |
|
— |
|
— |
|
|
— |
|
||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2020 |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| (in thousands, except per share amounts) | Common Stock | Additional Paid-In Capital | AOCI |
Retained
Earnings |
Total Shareholders' Equity | NCI |
Total
Equity |
|||||||||||||||||||
| Shares | Amount | |||||||||||||||||||||||||
|
BALANCE AS OF
DECEMBER 31, 2019 |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| Net earnings (loss) | — | — | — | — |
(
|
(
|
|
(
|
||||||||||||||||||
| Cumulative adjustment for the adoption of ASC 326 | — | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||
| OCI | — | — | — |
(
|
— |
(
|
(
|
(
|
||||||||||||||||||
|
Dividends ($
|
— | — | — | — |
(
|
(
|
— |
(
|
||||||||||||||||||
| Distributions to NCI | — | — | — | — | — | — |
(
|
(
|
||||||||||||||||||
| Capital contributions by NCI | — | — | — | — | — | — |
|
|
||||||||||||||||||
| Other NCI transactions | — | — |
|
— | — |
|
|
|
||||||||||||||||||
| Stock-based plan activity |
|
|
|
— |
|
|
— |
|
||||||||||||||||||
| BALANCE AS OF SEPTEMBER 30, 2020 |
|
$ |
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||
| (in thousands, except per share amounts) |
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||||
| 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||
| Net earnings (loss) from Cont Ops attributable to Fluor | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Less: Dividends on CPS |
|
|
|
|
||||||||||||||||||||||
| Net earnings (loss) from Cont Ops available to Fluor common stockholders |
|
|
(
|
|
||||||||||||||||||||||
| Net earnings (loss) from Disc Ops attributable to Fluor |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Net earnings (loss) available to Fluor common stockholders | $ |
|
$ |
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Weighted average common shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Diluted effect: | ||||||||||||||||||||||||||
|
CPS
(1)
|
|
|
|
|
||||||||||||||||||||||
|
Stock options, RSUs, restricted stock and performance-based award units
(2)
|
|
|
|
|
||||||||||||||||||||||
| Weighted average diluted shares outstanding |
|
|
|
|
||||||||||||||||||||||
| Basic EPS available to Fluor common stockholders: | ||||||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Diluted EPS available to Fluor common stockholders: | ||||||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ |
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Anti-dilutive securities not included in shares outstanding: | ||||||||||||||||||||||||||
| (1) CPS |
|
|
|
|
||||||||||||||||||||||
| (2) All others |
|
|
|
|
||||||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||
| Energy Solutions | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Urban Solutions |
|
|
|
|
||||||||||||||||||||||
| Mission Solutions |
|
|
|
|
||||||||||||||||||||||
| Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Segment profit (loss) | ||||||||||||||||||||||||||
| Energy Solutions | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Urban Solutions |
|
|
(
|
|
||||||||||||||||||||||
| Mission Solutions |
|
|
|
|
||||||||||||||||||||||
| Other |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Total segment profit (loss) | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| G&A |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Impairment, restructuring and other exit costs |
|
|
(
|
(
|
||||||||||||||||||||||
| Foreign currency gain (loss) |
|
(
|
(
|
|
||||||||||||||||||||||
| Interest income (expense), net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Earnings (loss) from Cont Ops attributable to NCI |
(
|
|
|
|
||||||||||||||||||||||
| Earnings (loss) from Cont Ops before taxes | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Intercompany revenue for our professional staffing business, excluded from revenue above | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| NuScale expenses | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| Less: DOE reimbursable expenses |
|
|
|
|
||||||||||||||||||||||
| NuScale expenses, net |
(
|
(
|
(
|
(
|
||||||||||||||||||||||
| Less: Attributable to NCI |
|
|
|
|
||||||||||||||||||||||
| Fluor segment loss | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||
| (in millions) |
September 30,
2021 |
December 31,
2020 |
||||||||||||
| Energy Solutions | $ |
|
$ |
|
||||||||||
| Urban Solutions |
|
|
||||||||||||
| Mission Solutions |
|
|
||||||||||||
| Other |
|
|
||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| North America | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
| Asia Pacific (includes Australia) |
|
|
|
|
||||||||||||||||||||||
| Europe |
|
|
|
|
||||||||||||||||||||||
| Central and South America |
|
|
|
|
||||||||||||||||||||||
| Middle East and Africa |
|
|
|
|
||||||||||||||||||||||
| Total revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||
|
9ME
September 30, |
|||||||||||||||||||||||
| (in thousands) | 2021 | 2020 | |||||||||||||||||||||
| Impairment expense: | |||||||||||||||||||||||
| Energy Solutions' equity method investment | $ |
|
$ |
|
|||||||||||||||||||
| Information technology assets |
|
|
|||||||||||||||||||||
| Total impairment expense | $ |
|
$ |
|
|||||||||||||||||||
| (in thousands) | Severance | Lease Exit Costs | Total | ||||||||
| Balance as of December 31, 2019 | $ |
|
$ |
|
$ |
|
|||||
| Restructuring charges accrued during the period |
|
|
|
||||||||
| Cash payments / settlements during the period |
(
|
(
|
(
|
||||||||
| Currency translation |
|
|
|
||||||||
| Balance as of December 31, 2020 | $ |
|
$ |
|
$ |
|
|||||
| Cash payments / settlements during the period | $ |
(
|
$ |
(
|
$ |
(
|
|||||
| Currency translation |
(
|
|
(
|
||||||||
| Balance as of September 30, 2021 | $ |
|
$ |
|
$ |
|
|||||
|
9ME
September 30, |
||||||||
| (in thousands) | 2021 | 2020 | ||||||
| Cash paid for: | ||||||||
| Interest | $ |
|
$ |
|
||||
| Income taxes (net of refunds) |
|
|
||||||
| (in millions) | September 30, 2021 | December 31, 2020 | ||||||
| Information about contract assets: | ||||||||
| Contract assets | ||||||||
| Unbilled receivables - reimbursable contracts | $ |
|
$ |
|
||||
| Contract work in progress - lump-sum contracts |
|
|
||||||
| Contract assets | $ |
|
$ |
|
||||
| Advance billings deducted from contract assets | $ |
|
$ |
|
||||
|
9ME
September 30, |
||||||||
| (in millions) | 2021 | 2020 | ||||||
| Information about contract liabilities: | ||||||||
| Revenue recognized that was included in contract liabilities as of January 1 | $ |
|
$ |
|
||||
| (in millions) | September 30, 2021 | ||||
| Within 1 year | $ |
|
|||
| 1 to 2 years |
|
||||
| Thereafter |
|
||||
| Total RUPO | $ |
|
|||
| (in thousands) | September 30, 2021 | December 31, 2020 | |||||||||
| Borrowings under credit facility | $ |
|
$ |
|
|||||||
| Current: | |||||||||||
| Other borrowings | $ |
|
$ |
|
|||||||
| Long-term: | |||||||||||
| Senior Notes | |||||||||||
| 2023 Notes | $ |
|
$ |
|
|||||||
| Unamortized discount on 2023 Notes |
(
|
(
|
|||||||||
| Unamortized deferred financing costs |
(
|
(
|
|||||||||
| 2024 Notes |
|
|
|||||||||
| Unamortized discount on 2024 Notes |
(
|
(
|
|||||||||
| Unamortized deferred financing costs |
(
|
(
|
|||||||||
| 2028 Notes |
|
|
|||||||||
| Unamortized discount on 2028 Notes |
(
|
(
|
|||||||||
| Unamortized deferred financing costs |
(
|
(
|
|||||||||
| Total long-term | $ |
|
$ |
|
|||||||
| September 30, 2021 | December 31, 2020 | |||||||||||||||||||||||||||||||||||||||||||||||||
| Fair Value Hierarchy | Fair Value Hierarchy | |||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Total | Level 1 | Level 2 | Level 3 | Total | Level 1 | Level 2 | Level 3 | ||||||||||||||||||||||||||||||||||||||||||
| Assets: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Deferred compensation trusts
(1)
|
$ |
|
$ |
|
$ | — | $ | — | $ |
|
$ |
|
$ | — | $ | — | ||||||||||||||||||||||||||||||||||
|
Derivative assets
(2)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency |
|
— |
|
— |
|
— |
|
— | ||||||||||||||||||||||||||||||||||||||||||
| Commodity |
|
— |
|
— |
|
— |
|
— | ||||||||||||||||||||||||||||||||||||||||||
| Liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||
|
Derivative liabilities
(2)
|
||||||||||||||||||||||||||||||||||||||||||||||||||
| Foreign currency | $ |
|
$ | — | $ |
|
$ | — | $ |
|
$ | — | $ |
|
$ | — | ||||||||||||||||||||||||||||||||||
| Commodity |
|
— |
|
— |
|
— |
|
— | ||||||||||||||||||||||||||||||||||||||||||
| September 30, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||
| (in thousands) |
Fair Value
Hierarchy |
Carrying
Value |
Fair
Value |
Carrying
Value |
Fair
Value |
||||||||||||||||||||||||
| Assets: | |||||||||||||||||||||||||||||
|
Cash
(1)
|
Level 1 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
|
Cash equivalents
(2)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
|
Marketable securities
(2)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
|
Notes receivable, including noncurrent portion
(3)
|
Level 3 |
|
|
|
|
||||||||||||||||||||||||
| Liabilities: | |||||||||||||||||||||||||||||
|
2023 Senior Notes
(4)
|
Level 2 | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
|
2024 Senior Notes
(4)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
|
2028 Senior Notes
(4)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
|
Other borrowings
(5)
|
Level 2 |
|
|
|
|
||||||||||||||||||||||||
| Performance-based Award Units Granted in 2021 |
Weighted Average
Grant Date Fair Value Per Share |
|||||||
| 2021 Performance Award Plan |
|
$
|
||||||
| 2020 Performance Award Plan |
|
$
|
||||||
| 2019 Performance Award Plan |
|
$
|
||||||
|
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||||||||
| (in thousands) | Location of Component | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||
| Service cost | Cost of revenue | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||
| Interest cost | Corp G&A |
|
|
|
|
||||||||||||||||||||||||
| Expected return on assets | Corp G&A |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
| Amortization of prior service credit | Corp G&A |
(
|
(
|
(
|
(
|
||||||||||||||||||||||||
| Recognized net actuarial loss | Corp G&A |
|
|
|
|
||||||||||||||||||||||||
| Net periodic pension expense | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||
| Asset Derivatives | Liability Derivatives | |||||||||||||||||||||||||||||||||||||
| (in thousands) |
Balance Sheet
Location |
September 30,
2021 |
December 31,
2020 |
Balance Sheet
Location |
September 30,
2021 |
December 31,
2020 |
||||||||||||||||||||||||||||||||
| Foreign currency contracts | Other current assets | $ |
|
$ |
|
Other accrued liabilities | $ |
|
$ |
|
||||||||||||||||||||||||||||
| Foreign currency contracts | Other assets |
|
|
Noncurrent liabilities |
|
|
||||||||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||
| Cash Flow Hedges (in thousands) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Foreign currency contracts |
|
|
|
|
|||||||||||||||||||
| Commodity contracts |
|
|
|
(
|
|||||||||||||||||||
|
|
|
|
|
||||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||||||||
| Cash Flow Hedges (in thousands) | Location of Gain (Loss) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||||||
| Foreign currency contracts | Cost of revenue | $ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Commodity contracts | Cost of revenue |
|
|
|
(
|
|||||||||||||||||||||||||||
| Interest rate contracts | Interest expense |
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Total | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
|
3ME
September 30, 2021 |
3ME
September 30, 2020 |
|||||||||||||||||||||||||||||||||||||
| (in thousands) |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
||||||||||||||||||||||||||||||||
| OCI: | ||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | $ |
(
|
$ |
|
$ |
(
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI |
(
|
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| DB plan adjustments |
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Unrealized gain (loss) on hedges |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Total OCI |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Less: OCI attributable to NCI |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| OCI attributable to Fluor | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
|
||||||||||||||||||||||||||
|
9ME
September 30, 2021 |
9ME
September 30, 2020 |
|||||||||||||||||||||||||||||||||||||
| (in thousands) |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
Before-Tax
Amount |
Tax
Benefit (Expense) |
Net-of-Tax
Amount |
||||||||||||||||||||||||||||||||
| OCI: | ||||||||||||||||||||||||||||||||||||||
| Foreign currency translation adjustments | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
| DB plan adjustments |
|
|
|
|
|
|
||||||||||||||||||||||||||||||||
| Unrealized gain (loss) on hedges |
(
|
(
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||
| Total OCI |
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||
| Less: OCI attributable to NCI |
|
|
|
(
|
|
(
|
||||||||||||||||||||||||||||||||
| OCI attributable to Fluor | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||
| (in thousands) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Net OCI |
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
| Balance as of September 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Attributable to NCI: | |||||||||||||||||||||||||||||
| Balance as of June 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
|
|
|
|
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
| Net OCI |
|
|
|
|
|
||||||||||||||||||||||||
| Balance as of September 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| (in thousands) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||||||||
| Balance as of December 31, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
(
|
(
|
||||||||||||||||||||||||
| Net OCI |
(
|
(
|
|
(
|
(
|
||||||||||||||||||||||||
| Balance as of September 30, 2021 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Attributable to NCI: | |||||||||||||||||||||||||||||
| Balance as of December 31, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
|
|
|
|
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
| Net OCI |
|
|
|
|
|
||||||||||||||||||||||||
| Balance as of September 30, 2021 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| (in thousands) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
| Attributable to Fluor: | |||||||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
|
(
|
|
|
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
(
|
|
||||||||||||||||||||||||
| Net OCI |
|
(
|
|
|
|
||||||||||||||||||||||||
| Balance as of September 30, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Attributable to NCI: | |||||||||||||||||||||||||||||
| Balance as of June 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
| Net OCI |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Balance as of September 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| (in thousands) |
Foreign
Currency Translation |
Ownership
Share of Equity Method Investees’ OCI |
DB Plans |
Unrealized
Gain (Loss) on Hedges |
AOCI, Net | ||||||||||||||||||||||||
| Attributable to Fluor Corporation: | |||||||||||||||||||||||||||||
| Balance as of December 31, 2019 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
(
|
(
|
|
|
(
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
(
|
|
||||||||||||||||||||||||
| Net OCI |
(
|
(
|
|
|
(
|
||||||||||||||||||||||||
| Balance as of September 30, 2020 | $ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
|||||||||||||||||||
| Attributable to NCI: | |||||||||||||||||||||||||||||
| Balance as of December 31, 2019 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
| OCI before reclassifications |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Amounts reclassified from AOCI |
|
|
|
|
|
||||||||||||||||||||||||
| Net other comprehensive income (loss) |
(
|
|
|
|
(
|
||||||||||||||||||||||||
| Balance as of September 30, 2020 | $ |
(
|
$ |
|
$ |
|
$ |
|
$ |
(
|
|||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||||||||
| (in thousands) | Location in Statement of Operations | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||||||||||
| Component of AOCI: | ||||||||||||||||||||||||||||||||
| Ownership share of equity method investees’ OCI | Cost of revenue | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
| Income tax benefit | Income tax expense (benefit) |
|
|
|
|
|||||||||||||||||||||||||||
| Net of tax | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| DB plan adjustments | G&A | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
| Income tax benefit | Income tax expense (benefit) |
|
|
(
|
|
|||||||||||||||||||||||||||
| Net of tax | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||
| Unrealized gain (loss) on derivative contracts: | ||||||||||||||||||||||||||||||||
| Commodity and foreign currency contracts |
Various accounts
(1)
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Interest rate contracts | Interest expense |
(
|
(
|
(
|
(
|
|||||||||||||||||||||||||||
| Income tax benefit | Income tax expense (benefit) |
|
|
(
|
|
|||||||||||||||||||||||||||
| Net of tax | $ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||
|
3ME
September 30, 2021 |
9ME
September 30, 2021 |
9ME
September 30, 2020 |
|||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Stork | AMECO | Stork | AMECO | |||||||||||||||||||||||||||||
|
Impairment expense:
(1)
|
|||||||||||||||||||||||||||||||||||
| Goodwill | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
| Intangible customer relationships |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Fair value adjustment and expected costs associated with sale |
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total impairment expense | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||
|
3ME
September 30, 2021 |
3ME
September 30, 2020 |
||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Other | Total | Stork | AMECO | Other | Total | |||||||||||||||||||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||||||||||||||||
| Cost of revenue |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Gross Profit |
|
|
(
|
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
| G&A |
(
|
(
|
|
(
|
|
(
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Impairment expense |
|
(
|
|
(
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Foreign currency gain (loss) |
(
|
(
|
|
(
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Operating profit (loss) |
|
(
|
(
|
(
|
|
|
(
|
|
|||||||||||||||||||||||||||||||||||||||
| Interest (expense) income, net |
(
|
(
|
|
(
|
(
|
(
|
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Earnings (loss) before taxes from Disc Ops |
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Income tax expense (benefit) |
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Disc Ops |
|
(
|
(
|
(
|
(
|
|
(
|
(
|
|||||||||||||||||||||||||||||||||||||||
| Less: Net earnings (loss) from Disc Ops attributable to NCI |
|
(
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Disc Ops attributable to Fluor | $ |
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||||||||||
|
9ME
September 30, 2021 |
9ME
September 30, 2020 |
|||||||||||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Other | Total | Stork | AMECO | Other | Total | ||||||||||||||||||||||||||||||||||||||||||
| Revenue | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
||||||||||||||||||||||||||||||||||
| Cost of revenue |
|
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Gross profit |
|
|
(
|
|
(
|
|
(
|
|
||||||||||||||||||||||||||||||||||||||||||
| G&A |
(
|
(
|
|
(
|
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Impairment expense |
(
|
(
|
|
(
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Loss on sale of AMECO North America |
|
(
|
|
(
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Foreign currency gain (loss) |
(
|
|
|
|
(
|
(
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Operating profit (loss) |
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Interest (expense) income, net |
(
|
|
|
(
|
(
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Earnings (loss) before taxes from Disc Ops |
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Income tax expense (benefit) |
|
|
|
|
(
|
|
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Disc Ops |
(
|
(
|
(
|
(
|
(
|
(
|
(
|
(
|
||||||||||||||||||||||||||||||||||||||||||
| Less: Net earnings (loss) from Disc Ops attributable to NCI |
|
(
|
|
|
|
|
|
|
||||||||||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Disc Ops attributable to Fluor | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
||||||||||||||||||||||||||||||||||
| September 30, 2021 | December 31, 2020 | ||||||||||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Other | Total from Disc Ops | Other Assets and Liabilities from Cont Ops | Total | Stork | AMECO | Other | Total from Disc Ops | Other Assets and Liabilities from Cont Ops | Total | |||||||||||||||||||||||||||||
| Accounts receivable, net | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Contract assets |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Other current assets |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Current assets held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| PP&E, net |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Goodwill |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Investments |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Other assets |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Noncurrent assets held for sale
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total assets held for sale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Accounts payable | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
| Short-term borrowings |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Contract liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Accrued salaries, wages and benefits |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Other accrued liabilities |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Current liabilities held for sale |
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
|
Noncurrent liabilities held for sale
(1)
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||
| Total liabilities held for sale | $ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
$ |
|
|||||||||||||||||
|
9ME
September 30, |
|||||||||||||||||||||||||||||||||||
| 2021 | 2020 | ||||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Total | Stork | AMECO | Total | |||||||||||||||||||||||||||||
| Capital expenditures | $ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
$ |
(
|
|||||||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||||||||||||||
| Revenue | ||||||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 1,365.4 | $ | 1,337.9 | $ | 3,675.4 | $ | 4,195.2 | ||||||||||||||||||||||||||||||
| Urban Solutions | 1,014.7 | 1,329.4 | 3,419.2 | 4,434.2 | ||||||||||||||||||||||||||||||||||
| Mission Solutions | 723.0 | 789.6 | 2,183.4 | 2,260.2 | ||||||||||||||||||||||||||||||||||
| Total revenue | $ | 3,103.1 | $ | 3,456.9 | $ | 9,278.0 | $ | 10,889.6 | ||||||||||||||||||||||||||||||
| Segment profit (loss) $ and margin % | ||||||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 72.5 | 5.3 | % | $ | 96.2 | 7.2 | % | $ | 183.9 | 5.0 | % | $ | 133.0 | 3.2 | % | ||||||||||||||||||||||
| Urban Solutions | 17.8 | 1.8 | % | 29.3 | 2.2 | % | (20.8) | (0.6) | % | 119.2 | 2.7 | % | ||||||||||||||||||||||||||
| Mission Solutions | 27.9 | 3.9 | % | 24.5 | 3.1 | % | 116.5 | 5.3 | % | 66.3 | 2.9 | % | ||||||||||||||||||||||||||
| Other | (8.2) | NM | (21.6) | NM | (42.4) | NM | (62.9) | NM | ||||||||||||||||||||||||||||||
|
Total segment profit (loss) $ and margin %
(1)
|
$ | 110.0 | 3.5 | % | $ | 128.4 | 3.7 | % | $ | 237.2 | 2.6 | % | $ | 255.6 | 2.3 | % | ||||||||||||||||||||||
| G&A | (42.4) | (36.7) | (139.4) | (112.9) | ||||||||||||||||||||||||||||||||||
| Impairment, restructuring and other exit costs | — | — | (26.4) | (106.2) | ||||||||||||||||||||||||||||||||||
| Foreign currency gain (loss) | 37.5 | (29.8) | (4.2) | 16.2 | ||||||||||||||||||||||||||||||||||
| Interest expense, net | (31.4) | (11.9) | (59.3) | (26.9) | ||||||||||||||||||||||||||||||||||
| Earnings (loss) from Cont Ops attributable to NCI | (3.5) | 4.2 | 21.5 | 19.7 | ||||||||||||||||||||||||||||||||||
| Earnings (loss) from Cont Ops before taxes | 70.2 | 54.2 | 29.4 | 45.5 | ||||||||||||||||||||||||||||||||||
| Income tax (expense) benefit | (27.0) | (28.5) | (28.8) | 2.4 | ||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Cont Ops | $ | 43.2 | $ | 25.7 | $ | 0.6 | $ | 47.9 | ||||||||||||||||||||||||||||||
| Less: Net earnings (loss) from Cont Ops attributable to NCI | (3.5) | 4.2 | 21.5 | 19.7 | ||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Cont Ops attributable to Fluor | $ | 46.7 | $ | 21.5 | $ | (20.9) | $ | 28.2 | ||||||||||||||||||||||||||||||
| Less: Dividends on CPS | 9.8 | — | 14.6 | — | ||||||||||||||||||||||||||||||||||
| Net earnings (loss) from Cont Ops available to Fluor common stockholders | $ | 36.9 | $ | 21.5 | $ | (35.5) | $ | 28.2 | ||||||||||||||||||||||||||||||
| New awards | ||||||||||||||||||||||||||||||||||||||
| Energy Solutions | $ | 644.1 | $ | 141.2 | $ | 2,914.1 | $ | 1,880.8 | ||||||||||||||||||||||||||||||
| Urban Solutions | 781.4 | 950.8 | 2,459.9 | 3,349.2 | ||||||||||||||||||||||||||||||||||
| Mission Solutions | 1,610.3 | 187.8 | 2,694.5 | 1,813.1 | ||||||||||||||||||||||||||||||||||
| Total new awards | $ | 3,035.8 | $ | 1,279.8 | $ | 8,068.5 | $ | 7,043.1 | ||||||||||||||||||||||||||||||
| New awards related to projects located outside of the U.S. | 55% | 50% | ||||||||||||||||||||||||||||||||||||
| Backlog |
September 30,
2021 |
December 31,
2020 |
||||||||||||
| Energy Solutions | $ | 9,804.5 | $ | 11,020.5 | ||||||||||
| Urban Solutions | 7,827.5 | 9,224.1 | ||||||||||||
| Mission Solutions | 3,395.0 | 2,899.5 | ||||||||||||
| Total backlog | $ | 21,027.0 | $ | 23,144.1 | ||||||||||
| Backlog related to projects located outside of the U.S. | 64% | 64% | ||||||||||||
| Backlog related to lump-sum projects | 61% | 60% | ||||||||||||
|
9ME
September 30, |
|||||||||||||||||||||||
| (in thousands) | 2021 | 2020 | |||||||||||||||||||||
| Impairment expense: | |||||||||||||||||||||||
| Energy Solutions' equity method investment | $ | 26,392 | $ | 86,096 | |||||||||||||||||||
| Information technology assets | — | 16,269 | |||||||||||||||||||||
| Total impairment expense | $ | 26,392 | $ | 102,365 | |||||||||||||||||||
|
3ME
September 30, 2021 |
9ME
September 30, 2021 |
9ME
September 30, 2020 |
|||||||||||||||||||||||||||||||||
| (in thousands) | Stork | AMECO | Stork | AMECO | Stork | AMECO | |||||||||||||||||||||||||||||
| Impairment expense: | |||||||||||||||||||||||||||||||||||
| Goodwill | $ | — | $ | — | $ | 12,700 | $ | — | $ | 168,568 | $ | 12,300 | |||||||||||||||||||||||
| Intangible customer relationships | — | — | — | — | 26,671 | — | |||||||||||||||||||||||||||||
| Fair value adjustment and expected costs associated with sale | — | 4,809 | 60,500 | 53,085 | — | 87,700 | |||||||||||||||||||||||||||||
| Total impairment expense | $ | — | $ | 4,809 | $ | 73,200 | $ | 53,085 | $ | 195,239 | $ | 100,000 | |||||||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
|||||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | ||||||||||||||||||||||
| NuScale expenses | $ | (42.9) | $ | (43.3) | $ | (122.6) | $ | (119.2) | ||||||||||||||||||
| Less: DOE reimbursable expenses | 18.1 | 20.4 | 49.9 | 53.8 | ||||||||||||||||||||||
| NuScale expenses, net | (24.8) | (22.9) | (72.7) | (65.4) | ||||||||||||||||||||||
| Less: Attributable to NCI | 16.6 | 1.3 | 30.3 | 2.5 | ||||||||||||||||||||||
| Fluor segment loss | $ | (8.2) | $ | (21.6) | $ | (42.4) | $ | (62.9) | ||||||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| G&A | |||||||||||||||||||||||
| Compensation | $ | 22.4 | $ | 12.9 | $ | 103.9 | $ | 58.3 | |||||||||||||||
| Severance | 4.4 | 0.5 | 6.7 | 2.6 | |||||||||||||||||||
| SEC investigation / Internal review costs | 6.3 | 18.3 | 10.1 | 31.6 | |||||||||||||||||||
| Other | 9.3 | 5.0 | 18.7 | 20.4 | |||||||||||||||||||
| G&A | $ | 42.4 | $ | 36.7 | $ | 139.4 | $ | 112.9 | |||||||||||||||
|
3ME
September 30, |
9ME
September 30, |
||||||||||||||||||||||
| (in millions) | 2021 | 2020 | 2021 | 2020 | |||||||||||||||||||
| Net interest expense | |||||||||||||||||||||||
| Recurring interest expense | $ | 16.0 | $ | 15.7 | $ | 50.0 | $ | 47.9 | |||||||||||||||
| Costs to refinance our credit facility | — | — | 2.0 | — | |||||||||||||||||||
| Loss on debt repurchases | 19.6 | — | 19.6 | — | |||||||||||||||||||
| Interest income | (4.2) | (3.8) | (12.3) | (21.0) | |||||||||||||||||||
| Net interest expense | $ | 31.4 | $ | 11.9 | $ | 59.3 | $ | 26.9 | |||||||||||||||
|
9ME
September 30, |
||||||||||||||
| (in thousands) | 2021 | 2020 | ||||||||||||
| OPERATING CASH FLOW | $ | (219,549) | $ | 144,240 | ||||||||||
| INVESTING CASH FLOW | ||||||||||||||
| Proceeds from sales and maturities (purchases) of marketable securities | (43,747) | (10,250) | ||||||||||||
| Capital expenditures | (54,550) | (80,786) | ||||||||||||
| Proceeds from sales of assets incl. AMECO-North America | 125,374 | 54,849 | ||||||||||||
| Investments in partnerships and joint ventures | (79,847) | (25,252) | ||||||||||||
| Other | (12,169) | 4,690 | ||||||||||||
| Investing cash flow | (64,939) | (56,749) | ||||||||||||
| FINANCING CASH FLOW | ||||||||||||||
| Proceeds from issuance of CPS | 582,000 | — | ||||||||||||
| Purchases and retirement of debt | (525,212) | — | ||||||||||||
| Dividends paid (on CPS in 2021 and common stock in 2020) | (9,425) | (28,720) | ||||||||||||
| Other borrowings (debt repayments) | (6,673) | 13,527 | ||||||||||||
| Distributions paid to NCI | (20,158) | (19,288) | ||||||||||||
| Capital contributions by NCI | 201,511 | 82,109 | ||||||||||||
| Other | (3,953) | (1,669) | ||||||||||||
| Financing cash flow | 218,090 | 45,959 | ||||||||||||
| Effect of exchange rate changes on cash | (6,868) | (36,867) | ||||||||||||
| Increase (decrease) in cash and cash equivalents | (73,266) | 96,583 | ||||||||||||
| Cash and cash equivalents at beginning of period | 2,198,781 | 1,997,199 | ||||||||||||
| Cash and cash equivalents at end of period | $ | 2,125,515 | $ | 2,093,782 | ||||||||||
| Cash paid during the period for: | ||||||||||||||
| Interest | $ | 80,796 | $ | 54,677 | ||||||||||
| Income taxes (net of refunds) | 59,246 | 29,367 | ||||||||||||
|
3ME
September 30, |
||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Backlog, June 30 | $ | 21,073.9 | $ | 26,802.7 | ||||||||||
| New awards | 3,035.8 | 1,279.8 | ||||||||||||
| Adjustments and cancellations, net | (5.1) | 813.5 | ||||||||||||
| Work performed | (3,077.6) | (3,432.9) | ||||||||||||
| Backlog, September 30 | $ | 21,027.0 | $ | 25,463.1 | ||||||||||
|
9ME
September 30, |
||||||||||||||
| (in millions) | 2021 | 2020 | ||||||||||||
| Backlog, January 1 | $ | 23,144.1 | $ | 29,392.3 | ||||||||||
| New awards | 8,068.5 | 7,043.1 | ||||||||||||
|
Adjustments and cancellations, net
(1)
|
(986.0) | (169.9) | ||||||||||||
| Work performed | (9,199.6) | (10,802.4) | ||||||||||||
| Backlog, September 30 | $ | 21,027.0 | $ | 25,463.1 | ||||||||||
| Period |
Total Number
of Shares Purchased |
Average
Price Paid per Share |
Total Number
of Shares Purchased as Part of Publicly Announced Plans or Programs |
Maximum
Number of
Shares that May
Yet Be Purchased
Under the Plans or
Program
(1)
|
||||||||||||||||||||||
| July 1 — July 31, 2021 | — | $ | — | — | 10,513,093 | |||||||||||||||||||||
| August 1 — August 31, 2021 | — | — | — | 10,513,093 | ||||||||||||||||||||||
| September 1 — September 30, 2021 | — | — | — | 10,513,093 | ||||||||||||||||||||||
| Total | — | $ | — | — | ||||||||||||||||||||||
| Exhibit | Description | |||||||
| 3.1 | ||||||||
| 3.2 | ||||||||
| 3.3 | ||||||||
| 31.1 | ||||||||
| 31.2 | ||||||||
| 32.1 | ||||||||
| 32.2 | ||||||||
| 101.INS | Inline XBRL Instance Document.* | |||||||
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document.* | |||||||
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document.* | |||||||
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document.* | |||||||
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document.* | |||||||
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document.* | |||||||
| 104 | The cover page from the Company's Q3 2021 10-Q for the three and nine months ended September 30, 2021, formatted in Inline XBRL (included in the Exhibit 101 attachments).* | |||||||
| FLUOR CORPORATION | |||||||||||
| Date: | November 5, 2021 | By: | /s/ Joseph L. Brennan | ||||||||
| Joseph L. Brennan | |||||||||||
| Chief Financial Officer | |||||||||||
| Date: | November 5, 2021 | By: | /s/ John C. Regan | ||||||||
| John C. Regan | |||||||||||
| Chief Accounting Officer | |||||||||||
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
Suppliers
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|